Physician profile
Gabriel Vaserstein
NPI 1013940105
$1,755.19
in general payments reported to CMS, 2019-2025
17 companies · $836 in 2025
The $836 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $109 · 2023: $66.38 · 2024: $606 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208 · Education: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.34 |
| Education | $299.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $564.20 | 2021-2025 | Dupixent |
| Janssen Biotech, INC. | $252.11 | 2024-2025 | Tremfya |
| Genzyme Corporation | $175.82 | 2024-2025 | |
| Ucb, INC. | $98.16 | 2021-2024 | Bimzelx |
| Abbvie INC. | $97.08 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $85.00 | 2021-2025 | |
| Amgen INC. | $83.07 | 2021-2024 | Otezla |
| Organon LLC | $70.67 | 2025 | Vtama |
| Incyte Corporation | $50.78 | 2024 | Opzelura |
| Lilly USA, LLC | $48.55 | 2022-2023 | Taltz |
| Allergan, INC. | $47.38 | 2022 | |
| Leo Pharma INC. | $46.47 | 2025 | |
| Organogenesis INC. | $45.04 | 2024-2025 | Via Matrix, Matrix |
| Dermavant Sciences, INC. | $25.27 | 2023 | Vtama |
| Sun Pharmaceutical Industries INC. | $25.00 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $20.73 | 2024 | Rhodoled Xl, Ameluz, Xepi |
| Almirall LLC | $19.86 | 2024 | Seysara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Vaserstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.